Baby Steps To Real-World Evidence Of Efficacy: External Controls Gain Popularity In Rare Disease Trials

 
• By Bridget Silverman
  
vr-crowd
Increasing familiarity with the possibilities and constraints of natural history data can only help industry and regulators alike.

More from Approval Standards

More from Pathways & Standards